Healthcare

Pipeline Analysis of Phase III Medical Therapeutic Devices: The Potential Game Changers and Growth Enablers

Non-invasive, Portable, and Digitally-integrated Therapeutic Medical Devices Redefining Treatment Scenario

INDUSTRY
Healthcare

RELEASE DATE
30-Sep-2020
REGION
Global
DELIVERABLE TYPE
Technology Research

RESEARCH CODE
D9C6-01-00-00-00
SKU
HC03344-GL-TR_24795
Yes
SHARE

Pipeline Analysis of Phase III Medical Therapeutic Devices: The Potential Game Changers and Growth Enablers
Published on: 30-Sep-2020 | SKU: HC03344-GL-TR_24795

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Therapeutic medical devices play a significant role in the long-term treatment of chronic conditions such as cancer and neurological diseases. Non-invasive therapeutic medical devices capable of offering home-based treatment provide high patient comfort and adherence to the prescribed therapy. With the changing preference of the patients, the medical device industry is experiencing a significantly high demand for non-invasive and home-based therapeutic medical devices.
The growth opportunity-technology (GO-TE) provides an overview of key therapeutic medical devices in the late stage (Phase-III) of clinical development or clinical trial. The report covers innovative therapeutic medical devices in the pipeline for key therapy areas such as cardiology, neurology, oncology, and orthopedics. It highlights key development trends and emerging market needs for therapeutic medical devices.
The GO-TE offers growth opportunities for players in the therapeutic medical devices segment and highlights key market expansion strategy and future roadmap of therapeutic medical device developments.

1.1 Scope of the Research

1.2 Research Methodology

1.2 Research Methodology (Continued)

1.3 Portable, Lightweight, and Easy-to-use Therapeutic Medical Devices to Improve Patient Engagement and Outcomes for Home-based Treatment

2.1 The Innovative Idea Becomes Reality by Collaborative Efforts of Fuelers, Innovation Catalysts, Regulators, and Physicians

2.2 Trial Design and Organization are the Key Differences in Clinical Trials for Drugs and Medical Devices

2.3 PMA is Required to be Completed by Investigational Medical Devices for its Intended Use

2.4 Innovative Medical Device that Does Not have Predicate are Classified under Class III

2.5 Non-invasive, Lightweight, and Portable Therapeutic Medical Devices are an Emerging Market Need

2.6 The Trends in Therapeutic Medical Devices are Shifting towards Digital Technology Adoption and Home-based Healthcare

3.1 Most of the Innovative Technologies in Late-Stage have Lightweight and Portable Feature to Make the Medical Devices Convenient for Patients

3.2 Many Phase-III Therapeutic Medical Device Clinical Trials are Targeting Cardiology and Oncology Complications

3.3 Non-invasive Medical Devices for the Treatment of Oncology to Decrease Pain and Anxiety Associated with Invasive Devices

3.4 Drug-eluting Medical Implants are Capable of Releasing Medications at the Required Site for Cardiology Complications

3.5 Innovative Medical Devices Enabling Minimally Invasive Procedures can Save Physicians’ Time and Improve their Efficiency

3.6 Non-invasive Neurostimulation Therapy Delivering Energy in a Controlled Manner can Play a Significant Role in the Treatment of Multiple Neurological Disorders

3.7 Digital Technologies such as Smartphone Apps can Enable Seamless Transfer of Patient Data among Healthcare Stakeholders

3.8 Innovative Sealant Technologies can Significantly Reduce Overall Surgery Time and Ensure Faster Patient Recovery

4.1 Non-invasive Treatment Device for Oncology

4.2 Non-focused Ultrasound System for Renal Denervation

4.3 Acoustic Energy for Increasing Blood Flow in Stroke Patients

4.4 Wearable Neuromodulation Therapy Device

5.1 MedTech Companies can Produce Portable and Lightweight Therapeutic Medical Devices for Increased Patient Engagement

5.2 Future Therapeutic Medical Devices with Integrated Digital Technologies can Play an Important Role in Healthcare

6.1 Growth Opportunity: Advanced Therapeutic Medical Device Innovations, 2020

6.2 Growth Opportunity: Non-invasive Therapeutic Medical Devices for Increasing Patient Comfort that Results in Improved Treatment Outcomes

6.3 Growth Opportunity: Therapeutic Medical Devices with Integrated Digital Technology for Advanced Research and Improving Treatment Outcomes

7.1 The Strategic Imperative 8™

7.1 The Strategic Imperative 8™

7.2 The Impact of the Top Three Strategic Imperatives on the Advanced Therapeutic Medical Device Industry

7.3 About the Growth Pipeline Engine

7.4 Growth Opportunities Fuel the Growth Pipeline Engine™

8.1 Key Contacts

8.1 Key Contacts (continued)

Your Next Steps

Why Frost, Why Now?

Legal Disclaimer


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

19 Nov 2026   |   Global   |   Technology Research

Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms

Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.